000 03380nam a22003975i 4500
001 84760
003 ES-MaUEC
005 20230207040439.0
007 cr nn 008mamaa
008 150827s2016 gw a s 001 0 eng d
020 _a9783319214344
024 7 _a10.1007/978-3-319-21434-4
_2doi
040 _aES-MaUEC
050 4 _aRM322
_b2016 EB
082 0 4 _a610
100 1 _aEadie, Mervyn J.
_0n 50030294
_948495
245 1 0 _aAntiepileptic Drugs and Pregnancy :
_bA Guide for Prescribers
_cby MJ. Eadie, FJE. Vajda
264 1 _aCham
_bSpringer International Publishing
_bImprint
_bAdis
_c2016
300 _a1 recurso en línea (XII, 232 p.)
_b24 ilustraciones, 6 ilustraciones en color
336 _aTexto (visual)
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
505 0 _a1. Introduction -- 2. Antiepileptic drugs and becoming pregnant -- Part I. Antiepileptic Drug Pharmacokinetics in Pregnancy -- 3. Antiepileptic drug disposition and pregnancy -- 4. The older antiepileptic drugs -- 5. Commonly used newer antiepileptic drugs -- 6. Antiepileptic drugs sometimes used in pregnancy -- Part II. Antiepileptic Drugs and the Foetus -- 7. Antiepileptic drugs, epileptic seizures and the foetus -- 8. Antiepileptic drugs and foetal malformations - a possible class effect -- 9. Particular antiepileptic drugs and foetal malformations -- 10. Antiepileptic drugs, cognition and neurodevelopment -- Part III. Antiepileptic Drug use and Pregnancy -- 11. Antiepileptic drug therapy: management issues and pregnancy -- 12. Antiepileptic drugs and pregnancy -- the future.
520 3 _aA description of our current understanding of antiepileptic drug use during pregnancy, this book includes chapters on the impact of seizures on the mother and developing child, changes in maternal physiology during pregnancy and its impact on drug disposition, and the pharmacokinetic differences between the various anti-seizure medications. It also deals with the possible harmful effects of antiepileptic drug exposure during pregnancy on the physical and intellectual development of the fetus. Clinicians have to balance the potential adverse effects of the medicine for the fetus and mother-to-be against the risks that uncontrolled seizures hold for both when treating pregnant women with antiepileptic drugs. Only recently have enough scientific data emerged to provide a rational basis for treatment decisions that take in both aspects. This work provides a single, accessible, and up-to-date resource for busy clinicians.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
650 7 _aAnticonvulsivos
_9144280
_0comprobar BNE19912516408
_2embne
650 7 _aObstetricia
_0comprobar BNE19900953186
_2embne
_9137907
700 1 _aVajda, F. J. E. (Frank J. E.)
_0n 85276051
_948496
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-21434-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901 _ai9783319214344
907 _a.b12940380
_b28-10-17
_c21-11-16
988 _aSpringer_Medicine_2016
998 _am
_a_alco
_a_vill
_b21-10-17
_cm
_dz
_eo
_feng
_ggw
_h0
945 _aRM322 .E23 2016 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11584816
_z06-04-17
999 _c84760
_d84760
_x1